The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

The proof is in the pudding: patient engagement in studying cannabidiol in mild cognitive impairment

Abstract Background Patient engagement (PE) in clinical trials has gained importance yet remains uncommon, particularly in patients with mild cognitive impairment (MCI), a critical precursor to Alzheimer’s disease (AD). Cannabidiol (CBD) shows potential in slowing MCI progression due to its neuropro...

Full description

Saved in:
Bibliographic Details
Main Authors: Antonia Keck, Julia-Sophia Scheuermann, Petra Scheerbaum, Elmar Graessel, Kirsten R. Müller-Vahl
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Mild cognitive impairment
Alzheimer’s disease
Cannabidiol
Cannabis-based medicine
Patient engagement
Patient and public involvement
Online Access:https://doi.org/10.1186/s12906-025-04753-w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items